Zerbor/iStock via Getty Images
TG Therapeutics (NASDAQ:TGTX) shares fell on Monday after the company reported its first quarter earnings below expectations, despite raising its full year guidance.
The company reported first quarter profit of $0.03 per share, falling short of consensus of $0.17 per share. Revenue for the